SCHEMBL30984100

SCHEMBL30984100

CC1(Oc2ncnc(NCc3ccccc3Cl)c2[N+](=O)[O-])CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA7 P43166 2/20 0.43
CA13 Q8N1Q1 2/20 0.43
MAPK1 P28482 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPT P10636 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HTT P42858 3/20 0.42
LMNA P02545 1/20 0.41
ALOX15 P16050 1/20 0.41
PRKCQ Q04759 7/20 0.41
AURKA O14965 1/20 0.39
RPS6KB1 P23443 1/20 0.39
CYP3A4 P08684 5/20 0.39
CYP2C9 P11712 4/20 0.39
CYP2D6 P10635 3/20 0.39
MAPK8 P45983 1/20 0.39
DCLK1 O15075 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30983869 0.86 CA1 (0.42) CA1CA2CA7CA13MAPK1
SCHEMBL30983876 0.85 HTT (0.59) CA1CA2CA7CA13MAPK1
SCHEMBL31268881 0.84 KMT2A (0.45) CA1CA2CA7CA13ALDH1A1
SCHEMBL30984084 0.82 CA1 (0.44) CA1CA2CA7CA13ALDH1A1
SCHEMBL31269026 0.82 CA1 (0.46) CA1CA2CA7CA13MAPK1
SCHEMBL31269514 0.82 CA1 (0.44) CA1CA2CA7CA13ALDH1A1
SCHEMBL4924562 0.79 MAPT (0.52) CA1CA2CA7CA13MAPK1
SCHEMBL30983943 0.79 MAPT (0.52) CA1CA2CA7CA13MAPK1
SCHEMBL30984080 0.79 CA1 (0.42) CA1CA2CA7CA13ALDH1A1
SCHEMBL30984020 0.78 CA1 (0.59) CA1CA2CA7CA13ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 WO disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 WO disclosed